Across respective Institute for Value-Based Medicine® (IVBM) events held successful 2022, the most-viewed contented from these events screen a assortment of topics successful oncology care.
The apical 5 most-viewed contented from assorted Institute for Value-Based Medicine® (IVBM) events hosted by The American Journal of Managed Care® (AJMC®) this twelvemonth included interviews connected disparities successful immunotherapy transportation and biosimilar implementation, arsenic good arsenic recaps focusing connected conversations astir value-based crab care.
Here is the most-viewed contented from our IVBM events successful 2022.
5. Multidisciplinary Care arsenic the Catalyst for Innovation successful Oncology
This recap focuses connected the IVBM lawsuit successful Atlanta, Georgia, held successful concern with Emory Winship Cancer Institute and chaired by Ryan Haumschild, PharmD, MS, MBA, manager of pharmacy services, Emory Healthcare and Emory Winship Cancer Institute.
At this IVBM event, speakers covered topics driving innovation successful multidisciplinary crab care, including the usage of biosimilars, broad genomic profiling, and precision medicine. Panelists besides discussed besides addressed disparities successful prostate crab attraction care and preventive strategies to code the rising menace of quality papillomavirus-related oropharynx cancer.
4. Dr Amila Patel Highlights Findings connected Disparities successful Immunotherapy Delivery
In this interrogation astatine the IVBM lawsuit successful Austin, Texas, successful concern with Texas Oncology, AJMC® spoke with Amila Patel, PharmD, main objective serviceman of Navigating Cancer, astir information presented astatine the American Society of Clinical Oncology yearly meeting. The study, which utilized information from Navigating Cancer, recovered that non-White patients are little apt to person immunotherapy for caput and cervix cancer. Here, Patel elaborates connected changes that tin beryllium made successful however immunotherapy is delivered.
3. Practices Have to Grapple With the Logistics of Insurers’ Preferred Biosimilars: Dr Lalan Wilfong
For AJMC®'s IVBM lawsuit successful concern with Texas Oncology, Lalan Wilfong, MD, vice president of payer relations & signifier translation astatine The US Oncology Network, explained that commercialized payers each person their ain preferred biosimilar, which makes it challenging for practices. However, it is important to enactment they person been engaged with the displacement to biosimilars, helium said.
2. Dr Timothy Murphy Discusses Successfully Implementing Biosimilars Into Community Cancer Practice
AJMC® sat down with Timothy Murphy, MD, aesculapian oncologist/hematologist with Rocky Mountain Cancer Centers (RMCC) astatine the IVBM lawsuit successful Greenwood Village, Colorado, successful concern with RMCC. According to Murphy, having a program successful spot to amended providers and the pharmacy squad has contributed to RMCC’s occurrence with rapidly implementing biosimilars,
1. Shifting Landscape of Care Delivery Is Impacting Value-Based Cancer Care
This recap focuses connected AJMC®'s IVBM lawsuit successful concern with Texas Oncology. Debra Patt, MD, PhD, MBA, enforcement vice president of argumentation and strategical initiatives astatine Texas Oncology, and seat of the IVBM event, explained that discussions of worth successful crab attraction should besides see the extortion of assemblage oncology, which allows patients to person attraction wherever they live. This IVBM lawsuit covered a scope of topics related to value-based crab care, including oral oncolytics, physics patient-reported outcomes, and authorities and national policy.
English (US)